Insights
Insights From Our Experts
Articles
Three Keys to Value for Unlocking the Promise of Cell Therapies
The cell therapy market continues to grow. Estimated at $101 billion in 2021, the global cell therapy market is projected to reach $247 billion by 2028, a CAGR of 13.64%.1 The revenue generation is being driven…
Macroeconomic Factors Impact Cash Flow for Pharma
Worldwide inflation, ongoing effects of the COVID-19 pandemic and other macroeconomic factors continue to negatively impact established brands at a time when pharma companies need their positive cash flow the most to continue funding R&D. Leading…
How to Ensure Speed and Efficiency When Launching in Canada
Today is an extraordinary time for medical innovation. The pharmaceutical industry is yielding protection against diseases, focusing more on rare and complex disease treatments, and the world is getting better health outcomes. Global life expectancy is…
Reimagining the Patient Care Ecosystem
Improving Access, Removing Barriers and Speeding Up Time to Therapy Patient demand for telehealth and a flood of industry challenges are disrupting the traditional healthcare landscape. Lack of patient awareness, access to care and overburdened clinicians…
Customer Centric Approach to Medical Affairs Leveraging Digital Technology
As technology advances the needs of healthcare professionals (HCPs) and patients evolve. The onset of the COVID-19 pandemic accelerated digital adoption among these groups. Medical Affairs departments now require a digital strategy in addition to medical…
EVERSANA’s Continued Commitment to Rare Disease
World Orphan Drug Congress USA 2022 As a continued commitment to the rare disease space, EVERSANA was a proud sponsor and participant of this year’s World Orphan Drug Congress USA (WODC). Leaders including Maria Kirsch, General…
Commercialization Strategies in Oncology — The Right Partner Can Reduce Risk and Boost Rewards
Whether you are an emerging company launching your first product or an established company expanding your portfolio, a number of parallel initiatives must be developed and executed to help your therapy get out of the shadow…
In the Emerging World of Prescription Digital Therapeutics (PDTs), Can You Really be Prescriptive?
Breaking Down the 5Cs of Clinical and Commercial Success The past 2+ years of my 12-year career as a client strategy and services lead has thrown me into the ever-evolving world of prescription digital therapeutics (PDTs).…
Is Telemedicine Here to Stay?
Prior to the COVID-19 pandemic, healthcare delivery had been predominantly face-to-face. COVID-19 exposed the capacity limits of the healthcare system, and forced the system to optimize its methods of healthcare delivery by considering non-conventional methods such…
Exploring a Need for Change of Clinical Trials in Digital Medicine | A DTx Europe Panel Discussion
Martin Culjat, Senior VP, Regulatory Innovation & Digital Medicine, EVERSANA joined a panel of experts at DTx Europe to discuss the need for change of clinical trials in digital medicine. The current framework for clinical trials in…